FIXX
Leverage Shares 2X Long FIX Daily ETF
Set alert
- YTD
- -52.67%
- 1 year
- -52.67%
- Open
- 6.59
- Prev close
- 7.81
- Mkt cap
- 3.02M
- Vol
- 6.51K
- Avg vol
- 5.63K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.59
- High
- 7.33
- Forward P/E
- -1.34
- Beta
- -0.11
- Short ratio
- 0.62
- Inst. own
- 46.76%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 9, 2024
- 50-d avg
- 13.80
- 200-d avg
- 16.10
- 1y target
- 1.50
Key statistics
- Market cap
- 3.02M
- Enterprise value
- -27.00M
- Trailing P/E
- 0.00
- Forward P/E
- -1.34
- PEG ratio
- 0.14
- Price / sales
- 2.61
- Price / book
- 0.04
- EPS (TTM)
- -35.10
- Beta
- -0.11
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 1.16M
- Revenue growth
- -100.00%
- Free cash flow
- -56.33M
- Total cash
- 82.65M
- Total debt
- 1.32M
- Return on equity
- -90.02%
- Shares outstanding
- 3.23M
- Short % of float
- 0.04%
- 50-day average
- 13.80
- 200-day average
- 16.10
Analyst view
Consensus: hold
- Strong buy2
- Buy2
- Hold0
- Sell0
- Strong sell0
Next earnings
May 9, 2024
Expected May 9, 2024. Consensus EPS estimate -0.23.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 9, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Mar 12, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
| Nov 14, 2023 | Sep 1, 2023 | -0.42 | — | — | — |
| Aug 14, 2023 | Jun 1, 2023 | -0.51 | — | — | — |
| May 11, 2023 | Mar 1, 2023 | -0.55 | — | — | — |
| Mar 9, 2023 | Dec 1, 2022 | -0.51 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 27, 2023 | Baird | down | Outperform | Neutral |
| May 14, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
| May 11, 2023 | Credit Suisse | reit | Neutral | Neutral |
| May 11, 2023 | Chardan Capital | main | Buy | Buy |
| Mar 15, 2023 | HC Wainwright & Co. | reit | — | Buy |
| Nov 16, 2022 | Chardan Capital | main | — | Buy |
About Leverage Shares 2X Long FIX Daily ETF
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases in the United States. The company offers proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a nuclease-free gene editing mobility, gene therapy or for various genetic disorders. Its earlier stage product candidates comprising HMI-202, an investigational gene therapy which completed IND-enabling studies for the treatment of metachromatic leukodystrophy; and HMI-104 which completed IND-enabling studies. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- homologymedicines.com
News
- Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023
- Stocks That Hit 52-Week Lows On Monday
- Stocks That Hit 52-Week Lows On Friday
- 79 Biggest Movers From Yesterday
- Stocks That Hit 52-Week Lows On Wednesday
- Stocks That Hit 52-Week Lows On Friday
- Stocks That Hit 52-Week Lows On Thursday
- Stocks That Hit 52-Week Lows On Tuesday
- Stocks That Hit 52-Week Lows On Monday
- Stocks That Hit 52-Week Lows On Thursday
Your note
Sign in to keep a note on FIXX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALLOWAY PAUL | President | Sale | Jan 2, 2024 | 28,036 |
| BLUM MICHAEL LEE | Officer | Sale | Jan 8, 2023 | 9,408 |
| COHN GABRIEL | Officer | Sale | Jan 4, 2022 | 2,629 |
| JORDAN JULIE | Officer | Sale | Aug 2, 2023 | 7,496 |
| KELLY TIMOTHY P | Chief Operating Officer | Sale | Jan 4, 2022 | 2,224 |
| MICHAUD CHARLES JR. | Officer and Treasurer | Sale | Jan 2, 2024 | 11,598 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Temasek Holdings (Private) Limited | 9.77% | 5,650,996 | 5.00M | Jun 29, 2023 |
| 5AM Venture Management, LLC | 7.85% | 4,535,919 | 4.01M | Jun 29, 2023 |
| Vanguard Group Inc | 3.54% | 2,046,442 | 1.81M | Jun 29, 2023 |
| Blackrock Inc. | 1.91% | 1,107,077 | 979.76K | Jun 29, 2023 |
| Citadel Advisors Llc | 1.25% | 721,101 | 638.17K | Jun 29, 2023 |
| Bank of America Corporation | 0.75% | 433,304 | 383.47K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.41% | 1,395,301 | 1.23M | Jun 29, 2023 |
| Vanguard Extended Market Index Fund | 0.93% | 535,943 | 474.31K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.35% | 200,147 | 195.48K | May 30, 2023 |
| BlackRock Advantage Small Cap Core Fund | 0.33% | 191,198 | 186.74K | May 30, 2023 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.25% | 145,600 | 128.86K | Jun 29, 2023 |
| Fidelity Total Market Index Fund | 0.11% | 61,627 | 60.19K | May 30, 2023 |